NCT00528359View on ClinicalTrials.gov

β-Cell Function in Schizophrenic Subjects on Atypical Antipsychotic drugS

CompletedOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

October 31, 2005

Study Completion Date

February 28, 2007

Conditions
Schizophrenia
Interventions
DRUG

quetiapine or olanzapine or risperidone or aripiprazole

Trial Locations (1)

1030

Sanatia Hospital, Brussels

All Listed Sponsors
lead

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER

NCT00528359 - β-Cell Function in Schizophrenic Subjects on Atypical Antipsychotic drugS | Biotech Hunter | Biotech Hunter